24 October 2024 Biologics Bullous Pemphigoid ‘Breakthrough’ mAb in moderate to severe bullous pemphigoid
24 October 2024 SPONSORED Musculoskeletal podcast New option for psoriatic arthritis and axial spondyloarthritis
10 October 2024 PBS Pharmaceuticals Psoriatic Athritis Spondyloarthritis Bimekizumab added to PBS for PsA and axSpA patients